Organon And Co

This phase 2 trial tested three different doses of a new hormonal intrauterine system (IUS) releasing etonogestrel against a standard copper IUD for contraception. 84 healthy women who had given birth took part to see how safe and acceptable the devices were, and how they affecte…

This study looked at whether the etonogestrel implant (Nexplanon), currently approved for 3 years of use, remains effective for up to 5 years. About 500 women aged 35 or younger who already had the implant for 3 years took part. Researchers tracked pregnancy rates and side effect…

This study tested whether adding ezetimibe to atorvastatin (a common cholesterol drug) works better than atorvastatin alone in people at very high risk for heart attacks or strokes. Researchers enrolled 137 adults with atherosclerotic cardiovascular disease and measured how much …

This study tested a cream called tapinarof in 406 people aged 2 and older with moderate to severe eczema. Participants applied the cream or a placebo once daily for 8 weeks. The main goal was to see if the cream could make skin clear or almost clear. Results are being analyzed to…

This study tested a new medication called OG-6219 in 354 women aged 18 to 49 with moderate to severe endometriosis-related pain. The goal was to see if three different doses could safely reduce pelvic pain compared to a placebo. The trial is complete, and results will show how we…

This study tested a cream called tapinarof in 36 children aged 2 to 17 with severe eczema covering large areas of skin. The goal was to see how much of the drug gets into the body and whether it is safe. Children applied the cream once daily, and researchers monitored side effect…

This study tested a cream called tapinarof on 407 people aged 2 and older with moderate to severe eczema (atopic dermatitis). Participants applied the cream or a placebo once daily for 8 weeks. The goal was to see if the cream could clear or nearly clear the skin rash better than…